Royal Biologics Announces FDA Clearance for Fibrinet® PRF Wound Matrix for the Management of Cutaneous Wounds

B HACKENSACK, N.J., April 7, 2026 /PRNewswire/ — Royal Biologics, a leader in regenerative medicine and advanced wound care technologies, today announced that Fibrinet® PRF…
posteditor
posteditor
Articles: 16137

Other News